Nanchang, Jiangxi Province - China October 14, 2021, the Toumai® laparoscopic surgical robot (Toumai®), which was independently developed by Shanghai MicroPort MedBot (Group) Co., Ltd. (MicroPort® MedBot®) successfully held the first phase training course on minimally invasive robot surgery of urology in Jiangxi Province, with the strong support of Prof. Gongxian Wang of the First Affiliated Hospital of Nanchang University, a well-known urological expert in China, led by Prof. Bin Fu, director of urology department. This is the first training program of surgical robot animal experiment covering urological surgery experts in hospitals of several counties and cities nationwide.

This training was composed of 2 training sessions: The first session was basic composition and operation skills of Toumai®. Followed the instruction of the senior lecturer from Clinical Training Department of MicroPort ® MedBot® , the surgeons were grouped to complete the basic operations such as tissue suture and lymph node dissection assisted by Toumai®; The second part took urological surgery as the guidance, carried on the animal experiment to simulate the operation. From simple pelvic lymph node dissection to difficult ureterovesical replantation, Toumai® had successfully performed challenging surgical procedures such as tissue resection and structural reconstruction and had been highly recognized by all experts.

The 3D vision system of Toumai® provides surgeons with three-dimensional and real surgical field of vision. Intuitive master-slave teleoperation is sensitive and easy to handle. Wrist surgical instruments are highly flexible. On the basis of satisfying the requirements of elaboration dissociation, it simplifies surgical operation, shortens learning curve, and allows doctors to experience the differences and advantages of the Laparoscopic surgery and the Laparoscopic robotic surgery. The successful application of Toumai® in urological surgery in animal experiments laid a solid foundation for domestic surgical robot to assist doctors in complex surgery.

Prof. Hanfeng Xu of Department of Urology at the First Affiliated Hospital of University of South China said, "After this training in animal experiments, we highly recognize the performance of Toumai®. We are convinced that Toumai® will promote the rapid development of robotic surgery in China. We are proud of the technical experience of domestic surgical robots and feel honored to witness and participate in the growth of Chinese-developed surgical robots."

Mr. Yu Liu, Chief Commercial Officer of MicroPort® MedBot®, said, "I am pleased to establish a provincial training center for domestic MicroPort® MedBot® with the First Affiliated Hospital of Nanchang University, which has set many world records for robotic surgery. We are honored to see many doctors from Jiangxi Province supporting and personally operating domestic surgical robots for animal experiments. We firmly believe that when our Chinese-developed robotic technology is popularized in county-level hospitals and more doctors can use them, the more patients will enjoy the benefits of robotic surgery. We will build a training center with hospitals, continuously strengthen cooperation with clinical experts, continuously innovate iterative products, and provide doctors and patients with high-quality, inclusive robotic intelligent surgery solutions."